Fertility Drugs and Breast Cancer Risk
The safety of fertility drugs has been a concern to physicians and patients alike. A new study assessing fertility drugs and breast cancer risk has reassuring results.
Go Digital for Mammography
Digital mammography is superior to screen-film mammography, and the digital technology has other patient benefits as well, a new study finds.
Don’t Let Flawed Studies Guide Screening Mammo Decisions, Experts Say
Mammography screening for breast cancer saves lives: this should be the message that physicians spread to colleagues and patients, say leading experts.
Annual Mammography May Be Unnecessary, New Study Suggests
The rationale for annual mammography in women aged 40 to 59 years needs to be reassessed in countries where adjuvant therapy for breast cancer is available.
New Breast Imaging Technique Improves Diagnostic Specificity
Near-infrared spectroscopy paired with MRI works with all cup sizes and may minimize biopsies performed due to inconclusive MRI findings after an abnormal mammogram finding.
Acupuncture—Real or Sham—May Alleviate Menopausal Symptoms From Breast Cancer Drug
Hot flashes and other vasomotor symptoms in postmenopausal women with breast cancer taking aromatase inhibitors were significantly improved after acupuncture, study finds.
Most People Don’t Understand the Genetic Risks for Breast Cancer
The publicity surrounding Angelina Jolie's preventive mastectomy was a missed opportunity to educate the public about the true risks of BRCA gene mutation.
Mitochondrial DNA May Be Biomarker for More Aggressive Breast Cancer
Human breast tissue tests link reduced amounts of mitochondrial DNA content with a greater incidence of metastatic breast cancer.
Study Finds Room for Improvement in Use of Breast MRI
In 4 years, the rate of women receiving breast MRI nearly tripled, but it is underused in women most at risk for breast cancer and overused in women at average risk.
FDA Approves First Treatment for Neoadjuvant Breast Cancer
Accelerated approval of Perjeta (pertuzumab) was granted by the FDA as part of a complete treatment regimen for patients with early stage breast cancer before surgery.